マイクロニードルの世界市場

世界のマイクロニードルの市場規模は、2023年の10億米ドルから、予測期間中は5.1%のCAGRで推移し、2028年末には13億米ドルの規模に成長すると予測されています。

固形マイクロニードルの部門は2023年の4億6,910万米ドルから、5.2%のCAGRで推移し、2028年末には6億580万米ドルに達すると予測されています。また、溶解マイクロニードルの部門は2023年の1億610万米ドルから、5.6%のCAGRで推移し、2028年末には1億3,950万米ドルに達すると予測されています。

当レポートでは、世界のマイクロニードルの市場を調査し、市場の定義・概要、市場影響因子および市場機会の分析、法規制環境、市場規模の推移・予測、各種区分・地域別の詳細分析、臨床試験・特許の動向、ESGの展開、競合情勢、主要企業のプロファイルなどをまとめています。

目次

第1章 イントロダクション

第2章 サマリー・ハイライト

第3章 市場概要

• 概要
• 実績
• マイクロニードルの材料と製造
• マイクロニードルのパイプライン
• 規制状況
• 製品リコール

第4章 市場力学

• 市場促進要因
• 潜在的な用途
• 皮膚科処置の需要の高まり
• 感染症の増加
• 低侵襲ドラッグデリバリーに対する需要の高まり
• 市場抑制要因
• デバイス使用のリスクと制限
• 厳しい規制シナリオ
• 市場機会
• 主要企業によるR&D
• 市場の課題
• 複雑な製造プロセス
• COVID-19による市場への影響

第5章 市場内訳：マイクロニードルタイプ別

• 市場概要
• 市場シェア・予測
• ソリッドマイクロニードル
• 中空マイクロニードル
• 溶解マイクロニードル
• コーティングマイクロニードル
• ハイドロゲルマイクロニードル

第6章 市場内訳：用途別

• 市場概要
• 市場シェア・予測
• 皮膚科
• 免疫生物学的管理
• 病気治療
• 病気診断

第7章 市場内訳：地域別

• 世界のマイクロニードル市場：地域別
• 北米
• 米国
• カナダ
• 欧州
• ドイツ
• 英国
• フランス
• イタリア
• スペイン
• その他の欧州
• アジア太平洋
• 日本
• 中国
• インド
• 韓国
• その他のアジア太平洋地域
• その他の地域

第8章 ESGの開発

• ESG：イントロダクション
• マイクロニードル業界の持続可能性：ESGの視点
• ESGの主要な問題
• マイクロニードル業界のESGパフォーマンス分析
• マイクロニードル市場におけるESGに対する消費者の意識
• ケーススタディ
• BCCによる総論

第9章 新興技術

• マイクロニードルの3Dプリンティング技術
• マイクロニードルによる薬物モニタリング
• 植物病害管理用マイクロニードル
• スマートマイクロニードル
• ナノテクノロジーを統合したマイクロニードル
• マイクロニードルのウェアラブルデバイスへの統合

第10章 臨床試験・特許分析

• 臨床試験分析
• 臨床試験分析：研究タイプ別
• 臨床試験分析：ステータス別
• 臨床試験分析：フェーズ別
• 臨床試験分析：地域別
• 特許分析
• 特許：年別
• 特許：上位出願人別
• 特許：主要保有者別
• 特許：管轄区域別

第11章 競合情報

• 市場シェア分析
• 主要企業の最近の動向

第12章 企業プロファイル

• BECTON, DICKINSON AND CO.
• CANDELA CORP.
• CLEARSIDE BIOMEDICAL
• COSMED PHARMACEUTICAL CO. LTD.
• CUTERA
• CYNOSURE
• DEBIOTECH SA
• LTS LOHMANN THERAPIE-SYSTEME AG
• MERCATOR MEDSYSTEMS INC.
• MI.TO.PHARM GMBH
• MICROPOINT TECHNOLOGIES
• NANOBIOSCIENCES LLC
• NANOPASS
• THERAJECT INC.
• VAXESS TECHNOLOGIES INC.

第13章 付録：頭字語

List of Tables

• Summary Table A : Global Market for Microneedles, by Type, Through 2028
• Summary Table B : Global Market for Microneedles, by Region, Through 2028
• Table 1 : Microneedle Materials
• Table 2 : Microneedles: Materials and Manufacturing
• Table 3 : Microneedle Pipeline
• Table 4 : Recalled Microneedle Products
• Table 5 : Comparison of Microneedles
• Table 6 : Global Market for Microneedles, by Type, Through 2028
• Table 7 : Types of Solid Microneedles and Fabrication Techniques
• Table 8 : Global Market for Solid Microneedles, by Region, Through 2028
• Table 9 : Compounds Delivered Using Hollow Microneedles
• Table 10 : Global Market for Hollow Microneedles, by Region, Through 2028
• Table 11 : Dissolvable Microneedle Pipeline
• Table 12 : Global Market for Dissolving Microneedles, by Region, Through 2028
• Table 13 : Global Market for Coated Microneedles, by Region, Through 2028
• Table 14 : Global Market for Hydrogel Microneedles, by Region, Through 2028
• Table 15 : Global Market for Microneedles, by Application, Through 2028
• Table 16 : Global Market for Microneedles in Dermatological Applications, by Region, Through 2028
• Table 17 : Global Market for Microneedles in Immunobiological Administration Applications, by Region, Through 2028
• Table 18 : Global Market for Microneedles in Disease Treatment Applications, by Region, Through 2028
• Table 19 : Global Market for Microneedles in Disease Diagnosis Applications, by Region, Through 2028
• Table 20 : Global Market for Microneedles, by Region, Through 2028
• Table 21 : North American Market for Microneedles, by Country, Through 2028
• Table 22 : Facial Rejuvenation Procedures in Europe, by Country, 2022
• Table 23 : European Market for Microneedles, by Country, Through 2028
• Table 24 : Tuberculosis Burden in Asian Countries, by Country, 2021
• Table 25 : Facial Rejuvenation Procedures in Asia, by Country, 2022
• Table 26 : Asia-Pacific Market for Microneedles, by Country, Through 2028
• Table 27 : Skin Rejuvenation Procedures in South America, by Country, 2022
• Table 28 : ESG Rankings for Microneedle Companies, 2023*
• Table 29 : ESG: Environmental Overview
• Table 30 : ESG: Social Overview
• Table 31 : ESG: Governance Overview
• Table 32 : BD: ESG Overview
• Table 33 : Clinical Trials on Microneedles, by Type of Study, October 2023
• Table 34 : Clinical Trials on Microneedles, by Status, October 2023
• Table 35 : Clinical Trials on Microneedles, by Phase, June 2023
• Table 36 : Clinical Trials on Microneedles, by Region, October 2023
• Table 37 : Patents Granted for Microneedles, by Top Applicant, 2018-2022
• Table 38 : Patents Granted for Microneedles, by Top Owner, 2018-2022
• Table 39 : Patents Granted for Microneedles, by Jurisdiction, 2018-2022
• Table 40 : Microneedles: Company Ranking
• Table 41 : Recent Developments, Global Microneedle Market, 2020-2023
• Table 42 : BD: Financials/Revenue, 2021 and 2022
• Table 43 : BD: Microneedle Products
• Table 44 : Candela: Microneedle Products
• Table 45 : Candela: Key Developments, 2020-2023
• Table 46 : Clearside Biomedical Inc.: Microneedle Products
• Table 47 : CosMED Pharmaceutical Co. Ltd.: Microneedle Products
• Table 48 : Cutera: Financials/Revenue, 2021 and 2022
• Table 49 : Cutera: Microneedle Products
• Table 50 : Cutera: Key Developments, 2020
• Table 51 : Cynosure: Microneedle Products
• Table 52 : Cynosure: Key Developments, 2020 and 2021
• Table 53 : Debiotech SA: Microneedle Products
• Table 54 : LTS Lohmann Therapie-Systeme AG: Microneedle Products
• Table 55 : LTS Lohmann Therapie-Systeme AG: Key Developments, 2021 and 2022
• Table 56 : Mercator MedSystems: Microneedle Products
• Table 57 : mi.to.pharm GmbH: Microneedle Products
• Table 58 : Micropoint Technologies: Microneedle Products
• Table 59 : nanoBioSciences LLC: Microneedle Products
• Table 60 : NanoPass: Microneedle Products
• Table 61 : NanoPass Technologies: Key Developments, 2021
• Table 62 : TheraJect Inc.: Microneedle Products
• Table 63 : Vaxess Technologies Inc.: Microneedle Products
• Table 64 : Vaxess Technologies Inc.: Key Developments, 2021-2023
• Table 65 : Acronyms Used in This Report

List of Figures

• Summary Figure A : Global Market for Microneedles, by Type, 2020-2028
• Summary Figure B : Global Market for Microneedles, by Region, 2020-2028
• Figure 1 : Transdermal Drug Delivery Methods
• Figure 2 : Microneedle Timeline, Since 1970s
• Figure 3 : Common Microneedle Manufacturing Methods
• Figure 4 : Microneedles: Market Dynamics
• Figure 5 : Estimates of Influenza Burden in the U.S., October 2022 to April 2023
• Figure 6 : Challenges in Manufacturing Microneedles
• Figure 7 : Global Market Shares of Microneedles, by Type, 2022
• Figure 8 : Solid Microneedles' Poke-and-patch Approach
• Figure 9 : Global Market for Solid Microneedles, by Region, 2020-2028
• Figure 10 : Hollow Microneedles' Poke-and-flow Approach
• Figure 11 : Global Market for Hollow Microneedles, by Region, 2020-2028
• Figure 12 : Dissolving Microneedles' Poke-and-release Approach
• Figure 13 : Global Market for Dissolving Microneedles, by Region, 2020-2028
• Figure 14 : Coated Microneedles' Coat-and-poke Approach
• Figure 15 : Global Market for Coated Microneedles, by Region, 2020-2028
• Figure 16 : Hydrogel Microneedle
• Figure 17 : Global Market for Hydrogel Microneedles, by Region, 2020-2028
• Figure 18 : Global Market Shares of Microneedles, by Application, 2022
• Figure 19 : Global Market for Microneedles in Dermatological Applications, by Region, 2020-2028
• Figure 20 : Global Market for Microneedles in Immunobiological Administration Applications, by Region, 2020-2028
• Figure 21 : Global Market for Microneedles in Disease Treatment Applications, by Region, 2020-2028
• Figure 22 : Global Market for Microneedles in Disease Diagnosis Applications, by Region, 2020-2028
• Figure 23 : Global Market Shares of Microneedles, by Region, 2022
• Figure 24 : North American Market Shares of Microneedles, by Country, 2022
• Figure 25 : U.S. Market for Microneedles, 2020-2028
• Figure 26 : Canadian Market for Microneedles, 2020-2028
• Figure 27 : European Market Shares of Microneedles, by Country, 2022
• Figure 28 : German Market for Microneedles, 2020-2028
• Figure 29 : U.K. Market for Microneedles, 2020-2028
• Figure 30 : French Market for Microneedles, 2020-2028
• Figure 31 : Italian Market for Microneedles, 2020-2028
• Figure 32 : Spanish Market for Microneedles, 2020-2028
• Figure 33 : Rest of European Market for Microneedles, 2020-2028
• Figure 34 : Asia-Pacific Market Shares of Microneedles, by Country, 2022
• Figure 35 : Japanese Market for Microneedles, 2020-2028
• Figure 36 : Chinese Market for Microneedles, 2020-2028
• Figure 37 : Indian Market for Microneedles, 2020-2028
• Figure 38 : South Korean Market for Microneedles, 2020-2028
• Figure 39 : Rest of Asia-Pacific Market for Microneedles, 2020-2028
• Figure 40 : Rest of the World Market for Microneedles, 2020-2028
• Figure 41 : ESG Pillars
• Figure 42 : Advantages of ESG for Companies
• Figure 43 : ESG Adoption Level Across All Industries, Global, 2021 and 2022
• Figure 44 : Share of ESG Penetration in the Microneedle Market, 2022
• Figure 45 : Patents Granted for Microneedles, by Year, 2018-2022
• Figure 46 : BD: Annual Financials/Revenue, 2021 and 2022
• Figure 47 : BD: Revenue Share, by Business Unit, 2022
• Figure 48 : BD: Revenue Share, by Region, 2022
• Figure 49 : Cutera Inc.: Annual Financials/Revenue, 2021 and 2022
• Figure 50 : Cutera Inc.: Revenue Share, by Business Unit, 2022
• Figure 51 : Cutera Inc.: Revenue Share, by Region, 2022

Highlights:

The global market for microneedles is expected to grow from $1.0 billion in 2023 to $1.3 billion by the end of 2028, at a compound annual growth rate (CAGR) of 5.1% from 2023 through 2028.

The global market for solid microneedles is expected to grow from $469.1 million in 2023 to $605.8 million by the end of 2028, at a CAGR of 5.2% from 2023 through 2028.

The global market for dissolving microneedles is expected to grow from $106.1 million in 2023 to $139.5 million by the end of 2028, at a CAGR of 5.6% from 2023 through 2028.

Report Scope:

The current report provides detailed information about the microneedle market. It highlights the current and future market potential for microneedles and provides a detailed analysis of the drivers, restraints, challenges, and opportunities in the market. The report also covers market projections for 2028 and includes the market rankings of key market players. It also covers the competitive environment and regulatory scenario.

The report details the market share of microneedles based on product and application. Based on product, the market is segmented into solid microneedles, hollow microneedles, coated microneedles, dissolving microneedles, and hydrogel microneedles. Based on application, the market is segmented into disease treatment, immunobiological administration, disease diagnosis, and dermatology applications. Hydrogel and disease diagnosis applications that are covered in the report are not commercially approved and are being used primarily by research organizations.

The market has been divided by geography into North America, Europe, Asia-Pacific, and the Rest of the World. The North American region comprises countries such as the U.S. and Canada; Europe includes Germany, the U.K., Italy, France, Spain, and the Rest of Europe; and Asia-Pacific includes China, India, Japan, South Korea, and the Rest of Asia-Pacific. For market estimates, data has been provided for 2020 and 2021 as the historical years and for 2022 as the base year, with forecasts for 2028.

Report Includes:

• 30 data tables and 37 additional tables
• An overview of the global market for microneedles
• Analysis of the global market trends, featuring historical revenue data for 2020 to 2022, estimated figures for 2023, as well as forecasts for 2028, including projections of compound annual growth rates (CAGRs) through 2028
• Evaluation of the current market size and revenue growth prospects, accompanied by a market share analysis by type, application and geographical region
• A look at the key market dynamics, the industry structure, regulatory landscape, current outlook and an analysis of the COVID-19 impact on the market for medical devices and microneedles
• Discussion of the properties of the latest generation of smart microneedles, such as skin adhesion, dissolvability, responsiveness and tip-substrate detachability, as well as whether they are bionic, bioderived or biocompatible in nature
• Review of patents on microneedle array technologies by assignee and products in the pipeline
• Coverage of evolving technologies, ESG trends and clinical trials
• Competitive benchmarking of key players, categorized by dermatology and vaccine and drug delivery, and their growth strategies
• Profiles of leading market participants

Table of Contents

Chapter 1 Introduction

• Study Goals and Objectives
• Reasons for Doing This Study
• Scope of Report
• What's New in This Report?
• Research Methodology
• Information Sources
• Geographic Breakdown
• Segmentation Breakdown

Chapter 2 Summary and Highlights

• Market Outlook
• Highlights of the Market for Microneedles

Chapter 3 Market Overview

• Overview
• History
• Microneedle Materials and Manufacturing
• Microneedle Pipeline
• Regulatory Landscape
• Product Recalls

Chapter 4 Market Dynamics

• Market Drivers
• Potential Applications of Microneedles
• Rising Demand for Dermatology Procedures
• Increasing Number of Infectious Diseases
• Rising Demand for Minimally Invasive Drug Delivery
• Market Restraints
• Risks and Limitations of Using Microneedling Devices
• Stringent Regulatory Scenario
• Market Opportunities
• R&D of Microneedles by Key Players
• Market Challenges
• Complex Manufacturing Process
• Impact of COVID-19 on the Microneedle Market

Chapter 5 Market Breakdown by Type of Microneedle

• Market Overview
• Market Share and Forecast
• Solid Microneedles
• Hollow Microneedles
• Dissolving Microneedles
• Coated Microneedles
• Hydrogel Microneedles

Chapter 6 Market Breakdown by Application

• Market Overview
• Market Share and Forecast
• Dermatology
• Immunobiological Administration
• Disease Treatment
• Disease Diagnosis

Chapter 7 Market Breakdown by Region

• Global Market for Microneedles by Region
• North America
• U.S.
• Canada
• Europe
• Germany
• U.K
• France
• Italy
• Spain
• Rest of Europe
• Asia-Pacific
• Japan
• China
• India
• South Korea
• Rest of Asia-Pacific
• Rest of the World

Chapter 8 ESG Development

• Introduction to ESG
• Sustainability in Microneedle Industry: An ESG Perspective
• Key ESG Issues
• Microneedle Industry ESG Performance Analysis
• Consumer Attitudes toward ESG in the Microneedle Market
• Case Study
• Concluding Remarks from BCC

Chapter 9 Emerging Technologies

• Introduction
• 3D-Printing Technology in Microneedles
• Drug Monitoring with Microneedles
• Microneedle for Plant Disease Management
• Smart Microneedles
• Nanotechnology-Integrated Microneedles
• Integration of Microneedles into Wearable Devices

Chapter 10 Clinical Trials and Patent Analysis

• Clinical Trial Analysis
• Clinical Trial Analysis, by Type of Study
• Clinical Trial Analysis, by Status
• Clinical Trial Analysis, by Phase
• Clinical Trial Analysis, by Region
• Patent Analysis
• Patents by Year
• Patents by Top Applicant
• Patents by Top Patent Holder
• Patents by Jurisdiction

Chapter 11 Competitive Intelligence

• Market Share Analysis
• Recent Developments of Key Companies

Chapter 12 Company Profiles

• BECTON, DICKINSON AND CO.
• CANDELA CORP.
• CLEARSIDE BIOMEDICAL
• COSMED PHARMACEUTICAL CO. LTD.
• CUTERA
• CYNOSURE
• DEBIOTECH SA
• LTS LOHMANN THERAPIE-SYSTEME AG
• MERCATOR MEDSYSTEMS INC.
• MI.TO.PHARM GMBH
• MICROPOINT TECHNOLOGIES
• NANOBIOSCIENCES LLC
• NANOPASS
• THERAJECT INC.
• VAXESS TECHNOLOGIES INC.

Chapter 13 Appendix: Acronyms